Literature DB >> 22696500

Active squamous metaplasia of the cervical epithelium is associated with subsequent acquisition of human papillomavirus 16 infection among healthy young women.

Loris Y Hwang1, Yifei Ma, Stephen C Shiboski, Sepideh Farhat, Janet Jonte, Anna-Barbara Moscicki.   

Abstract

BACKGROUND: Vulnerability of younger women to human papillomavirus 16 (HPV16) infection has been attributed to the predominance of ectocervical columnar epithelia in this age group. However, squamous metaplastic tissue may be more influential. We examined the extent of ectopy and metaplastic activity as risks for HPV16 acquisition in a prospective cohort.
METHODS: Participants were HPV16 negative at the first two visits. Follow-up occurred every 4 months. Ectopy was quantitatively measured on colpophotographs. We calculated metaplastic rate as the difference in ectopy between visits. Cox proportional hazards models were constructed, adjusting for several covariates.
RESULTS: Analyses included 198 women (mean baseline age 17 years) for 1734 visits. Mean follow-up was 4.4 years. Incident HPV16 was detected in 36 (18%) women. Metaplastic rate between the two visits before HPV16 detection was significantly associated with incident infection (hazard ratio [HR], 1.17; confidence interval [CI], 1.02-1.33; P = .02). However, ectopy was not significant, whether measured before or concurrent to HPV16 detection (HR range, 0.99-1.00; CI range, .97-1.02; P range, .47-.65).
CONCLUSIONS: Dynamic metaplasia rather than the sheer extent of ectopy appears to increase risk for incident HPV16 in healthy young women. This in vivo observation is consistent with the HPV life cycle, during which host cell replication and differentiation supports viral replication.

Entities:  

Mesh:

Year:  2012        PMID: 22696500      PMCID: PMC3491738          DOI: 10.1093/infdis/jis398

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

1.  Concomitant Chlamydia trachomatis and human papilloma virus infection cannot be attributed solely to sexual behaviour.

Authors:  V Verhoeven; M Baay; J Weyler; D Avonts; F Lardon; P Van Royen; J B Vermorken
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-08-18       Impact factor: 3.267

2.  Regression of low-grade squamous intra-epithelial lesions in young women.

Authors:  Anna-Barbara Moscicki; Stephen Shiboski; Nancy K Hills; Kimberly J Powell; Naomi Jay; Evelyn N Hanson; Susanna Miller; K Lisa Canjura-Clayton; Sepidah Farhat; Jeanette M Broering; Teresa M Darragh
Journal:  Lancet       Date:  2004 Nov 6-12       Impact factor: 79.321

3.  Covariates of cervical cytokine mRNA expression by real-time PCR in adolescents and young women: effects of Chlamydia trachomatis infection, hormonal contraception, and smoking.

Authors:  Mark E Scott; Yifei Ma; Sepideh Farhat; Stephen Shiboski; Anna-Barbara Moscicki
Journal:  J Clin Immunol       Date:  2006-05-16       Impact factor: 8.317

4.  Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines.

Authors:  Fabian Mendez; Nubia Munoz; Hector Posso; Monica Molano; Victor Moreno; Adrian J C van den Brule; Margarita Ronderos; Chris Meijer; Alvaro Munoz
Journal:  J Infect Dis       Date:  2005-08-29       Impact factor: 5.226

5.  Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.

Authors:  P E Gravitt; C L Peyton; R J Apple; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

6.  Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection.

Authors:  Jessica A Kahn; Susan L Rosenthal; Paul A Succop; Gloria Y F Ho; Robert D Burk
Journal:  Pediatrics       Date:  2002-01       Impact factor: 7.124

7.  Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results.

Authors:  Nubia Muñoz; Fabián Méndez; Héctor Posso; Mónica Molano; Adrian J C van den Brule; Margarita Ronderos; Chris Meijer; Alvaro Muñoz
Journal:  J Infect Dis       Date:  2004-11-22       Impact factor: 5.226

8.  The role of sexual behavior and human papillomavirus persistence in predicting repeated infections with new human papillomavirus types.

Authors:  Anna-Barbara Moscicki; Yifei Ma; Janet Jonte; Susanna Miller-Benningfield; Evelyn Hanson; Julie Jay; Cheryl Godwin de Medina; Sepideh Farhat; Lisa Clayton; Stephen Shiboski
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-08       Impact factor: 4.254

Review 9.  New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections.

Authors:  M von Knebel Doeberitz
Journal:  Eur J Cancer       Date:  2002-11       Impact factor: 9.162

10.  Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations.

Authors:  R Amsel; P A Totten; C A Spiegel; K C Chen; D Eschenbach; K K Holmes
Journal:  Am J Med       Date:  1983-01       Impact factor: 4.965

View more
  13 in total

Review 1.  Early Defensive Mechanisms against Human Papillomavirus Infection.

Authors:  Andrea Moerman-Herzog; Mayumi Nakagawa
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

2.  Feasibility of clinical detection of cervical dysplasia using angle-resolved low coherence interferometry measurements of depth-resolved nuclear morphology.

Authors:  Derek Ho; Tyler K Drake; Karen K Smith-McCune; Teresa M Darragh; Loris Y Hwang; Adam Wax
Journal:  Int J Cancer       Date:  2017-03-15       Impact factor: 7.396

3.  Biological and behavioral risks for incident Chlamydia trachomatis infection in a prospective cohort.

Authors:  Loris Y Hwang; Yifei Ma; Anna-Barbara Moscicki
Journal:  Obstet Gynecol       Date:  2014-11       Impact factor: 7.661

4.  Screening adolescents and young women.

Authors:  Lori A Boardman; Katina Robison
Journal:  Obstet Gynecol Clin North Am       Date:  2013-04-17       Impact factor: 2.844

5.  Past and future of prophylactic ablation of the cervical squamocolumnar junction.

Authors:  Silvia Franceschi
Journal:  Ecancermedicalscience       Date:  2015-04-29

6.  Cervical Ectropion and Intra-Uterine Contraceptive Device (IUCD): a five-year retrospective study of family planning clients of a tertiary health institution in Lagos Nigeria.

Authors:  Kikelomo Ololade Wright; Ahmadu Shehu Mohammed; Olajumoke Salisu-Olatunji; Yetunde Abiola Kuyinu
Journal:  BMC Res Notes       Date:  2014-12-23

Review 7.  The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next?

Authors:  Anita Mitra; David A MacIntyre; Julian R Marchesi; Yun S Lee; Phillip R Bennett; Maria Kyrgiou
Journal:  Microbiome       Date:  2016-11-01       Impact factor: 14.650

8.  Switches of SOX17 and SOX2 expression in the development of squamous metaplasia and squamous intraepithelial lesions of the uterine cervix.

Authors:  Jobran M Moshi; Klaas J Hoogduin; Monique Ummelen; Mieke E R Henfling; Manon van Engeland; Kim A D Wouters; Hans Stoop; Imke Demers; Leendert H J Looijenga; Frans C S Ramaekers; Anton N H Hopman
Journal:  Cancer Med       Date:  2020-07-09       Impact factor: 4.452

9.  Susceptibility of epithelial cells cultured from different regions of human cervix to HPV16-induced immortalization.

Authors:  Han Deng; Eric Hillpot; Philomina Yeboah; Sumona Mondal; Craig D Woodworth
Journal:  PLoS One       Date:  2018-06-26       Impact factor: 3.240

Review 10.  New cervical cancer screening guidelines: was the annual pap too much of a good thing?

Authors:  Margaret M Fields
Journal:  J Adv Pract Oncol       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.